The Cooper Companies, Inc. (COO) is a Healthcare stock trading at $66.04 (as of 2026-06-18), with a market capitalization of $11.94B and a trailing P/E of 57.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
The Cooper Companies, Inc. develops, manufactures, and markets vision and women’s health products through two segments: CooperVision, which offers contact lenses, and CooperSurgical, which provides medical devices and related services. These products are supplied to health care professionals and patients across regions including the Americas, Europe, Middle East, Africa, and Asia Pacific.